Provider review
YourHealthRx review
Sells both molecules as a dissolving tablet and an injection — and the cheaper route flips.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
$140/mo sema injectable · $190/mo tirz injectable, four products
Visit YourHealthRxThe injection undercuts the tablet on one molecule and the tablet undercuts the injection on the other.
Price as published
YourHealthRx
$140/mo sema injectable · $190/mo tirz injectable, four products
- Vs median
- $35/mo below the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The catalog is the reason to look here: two molecules, each sold as an injection and as a tablet that dissolves in the mouth, four figures, all readable before any intake. If your plan is to hold a deliberately small amount, the tablet is the more forgiving instrument, and having it offered for both drugs rather than just the cheap one is uncommon. What is genuinely unusual is the direction of the pricing. On one molecule the injection is the cheaper option and the tablet carries a premium; on the other that reverses, and the tablet is the cheaper of the two. Everywhere else a seller picks a direction — needle-free is either the upgrade or the entry point — and applies it to the whole catalog. Here the answer depends on which molecule you are on, which means optimizing for cost you cannot carry a rule across from one drug to the other and have to check both. All four numbers are floors, so what any of them buys at the top of a range is unstated, and no milligram appears behind any of them. The compounded status and the FDA's non-approval of compounded preparations are both disclosed rather than left implicit.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want a dissolving tablet available for either molecule, not just the cheaper one
- You want four figures visible before you answer anything
- You want compounded status and its regulatory position stated openly
Look elsewhere if
- You want one rule about which format is cheaper. It differs by molecule here
- You need a ceiling. All four figures are floors
- You want a dose behind the number. None is published
What it actually costs
Price as published
$140/mo sema injectable · $190/mo tirz injectable, four products
- Vs median
- $35/mo below the $175 median across the 299 of 548 programs here that publish a plain monthly rate
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
235 of the 548 programs here price a small dose this way. A dissolving tablet is offered for both molecules rather than only the cheaper one, which matters for a small dose because it avoids drawing a partial unit into a syringe. The cheaper route is not the same for both drugs: the injection undercuts the tablet on one molecule and the tablet undercuts the injection on the other, so if you are choosing on cost you cannot carry one rule across both, a pattern no other seller here shows. Every price is an "as low as" floor with no ceiling, and no dose is published behind any of the four. Compounded status and the FDA's non-approval are both disclosed.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not confirmed
- Labs
- Not required
- Pricing
- Check plan terms
What it does well
- Both molecules are offered as a dissolving tablet as well as an injection.
- All four figures are stated as monthly rates and readable before intake.
- Compounded status and the FDA's non-approval are disclosed on the page.
Pharmacy, labs and oversight
YourHealthRx does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What YourHealthRx publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
The catalog is the reason to look here: two molecules, each sold as an injection and as a tablet that dissolves in the mouth, four figures, all readable before any intake. For a reader whose plan is to hold a deliberately small amount, the tablet is the more forgiving instrument, and having it offered for both drugs rather than just the cheap one is uncommon. What is genuinely unusual is the direction of the pricing. On semaglutide the injection is the cheaper option and the tablet carries a premium; on tirzepatide that reverses, and the tablet is the cheaper of the two. Everywhere else on this page a seller picks a direction — needle-free is either the upgrade or the entry point — and applies it to the whole catalog. Here the answer depends on which molecule you are on, which means a reader optimizing for cost cannot carry a rule across from one drug to the other and has to check both. All four numbers are floors, so what any of them buys at the top of a range is unstated, and no milligram appears behind any of them. The compounded status and the FDA's non-approval of compounded preparations are both disclosed rather than left implicit.
The honest cons
Every figure is an "as low as" floor with no ceiling published.
- The cheaper route differs by molecule, so no single rule applies to the catalog.
- No dose sits behind any of the four figures.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
YourHealthRx is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way YourHealthRx does. Both are partners: we may earn a commission if you start care through these links.
Partner
Strut Health
$99/mo sema lozenge (auto-refill)
Standard plan, self-directed low dose
FDA warning letter · Strut Health · February 2026 · addressed to Strut Health, LLC dba Strut. Details in our review.
Partner
Willow
From $299/mo covering all four formats, none priced separately
Standard plan, self-directed low dose
Where this sits
#288 of 548
Ordered with the companies that pay us first, and YourHealthRx is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Sublingual troches and drops
- Oral semaglutide (Rybelsus)
- Microdose & reconstitution calculator
- The true annual cost of a plan
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Peter MD
$149/mo GLP1+B12 · $249/mo tirz (quarterly)
- Vs median
- $26/mo below the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Peter MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.